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CLARE-cNE S. HOEKSTRA
1939
The application of our recently acquired wealth of
knowledge on endoori•e physiology to the problems of
the menstrual cycle involves muoh "sifting of the chaff
in seeking the grain".

Though we have made great strides

forward in recent years in the field of endocrinology,
many gape still remain in our concepts.

The whole mech-

anism of endocrine inter-play as we interpet it today is
liable to change within a short time for several reasons.
One of the outstanding weaknesses of our present conception of the endocrines is tha.t only a fe•;v of the relationships are known faote.

The greater port ion are in real-

ity aesumpt ions based on clinical experience, a method
of investigation prone to fallacy because of the variability of factors whcih are difficru.lt or impoeeibe to
control in the human being.

One real value oY this

method, though, is that the work is on the human and by
the time the work is completed·, there is no need to
transfer findings from one species to another.

Another

weakness lies in the fact that controlled experiments
are for the most part on animals.

The bldnd transfer-

ence of animal findings to h1Jman phys ic:Dogy is a common
fault of "laboratory technicians" and cres,tes mu ch fal-

"181042
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1acious •knowledge•.

Though it is true that broad gen-

eralizations usually may be applied from speoiee to
epeciee, isolated fact tends to be species specific.
As e medical subject, we will of course stick to human findings aa closely as possible in this paper.
It is the aim of this paper to attempt to clarify
as much as possible the present status of the endocrines in relation to the menstrual cycle and to abnormalities of this cycle from etiological, diagnostic
and therapeutic standpoints, emphasizing the first and
last more than the diagnostic angle.
The history of endocrinology is a comparatively
recent one.

Though the ancients back as far as Hippoc;;,.o

rates postulated the humoral theory of physiology and
the suggestions of ferments in the body are found in
the writings of Sylviue, Willis, and others in the
seventeenth century, it was not until the.nineteenth
century and more particula.rly the last twenty-five
years of that period that we can list much in the way
of true endocrine knowledge or resea.rch.

Berthold,

Bernard and Brown-Sequard are probably the original
founders of modern endocrinology.

It was Brown-Sequard,

who in 1888 created a great interest and furor not only
in the medical profession but among the laity as well
by his announcement of a rejuvenating process by use
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of extracts of animal testes.

The biggest contributions

to our knowledge of the endocrine• ha.a been from the experimental work completed •!nee.the turn of the century.
Until more recently, many of the profession were very
skeptical of the endocrines and their complexity.

The

recent past has seen some remarkallle work so that now
the glands have many converts.

It would appear that the

'

waive of enthuei8.lllll ie in its aacendenay at this time.
It is necessary to thoroughly understand the basic
no1rmal physiology of these structures before we can
c~early

evaluate the pathological entities.

We must

tllerefore diacuas the present conception of the bormones
ofi menstruation and their inter-play before we attack
t~e

problem of anomalies of this cycle.
Since the ovary ia the principal endocrine of the

t•l• that
t

I1

!
i

distinguishes her from the male, it wi~l

be our first concern.

The ovary has two main functions·;

t1he produoti on of ova and its endocrine activity.

Both

of theee actions, though racially impGrtant, are not
eaeential to the life of the individual in contrast to
m~y

of the other glands of internal secretion such as

the hypophysis, the adrenals, the

pancrea~

and others.

P1'ofound metabolic dieturba.noes follow removal of the
t~roid,

the parathyroids, the pituita.ry and other

glands whitle removal of the ovary at any epoch of life
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produces much less striking effects on body functions.
Both of the ovarian functions, however,, are intimately
a part of the normally balanced endocrine system.
The ovary produces two types of eex hormones, the
estrogenic hormones and the corpus luteum. hormone.
estrogenic substances are three in number.

The

The name•

which are recommended by the Council of 'harmacy and
Chemistry of the American Medical Association are:
1. Eatradiol or dihydrothee1in.

This is most probably

the hormone that is actually evolved by the follicle.
(MacCorquodale, Thayer and Doisy,

a.

Eatrone or theelin.

1~35)

This hormone is found in urine

and ia probably an excretion product formed from estradiol.
3. Eetriol or theelol.

.Another estrogen found ae an

excretory product in urine.

The.se three. substances all

have similar but not identical properties.
Estrogenio substances have a very wide

distri~tion,

not only in the animal kingdom but also in the realm of
J
I

inanimate organic subeta.nc-es.

It ie found in the ovary,

in the blood, in the excreta of all of the vertebrates;
in invertebrates end in plants; and in such organic subst anoea as lignite, coal and petroleum.

Zondek showed

that the theotl, the granulosa cells and the corpus luteum
all produce the follicular hormone.

Chemically these
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substances are closely related to the sterols, the male
sex hormones and the carcinogenic hydrogenated phenantbrene ring compounds, a subject we will comment on later.
Since about 1930 voluminous literature has appeared on
these hormones.

The eetrogenic hormones were the first

known of the ovarian hormones and were thought for a "-'
time to be the sole hormone of menstruation.

Consider-

able argument was rampant from 1926 to 1928 as to whether
there was another hormone of menstruation.

Doiey, et al

(1929), obtained and publishei\ an article on follioulin
from the urine of pregnant women.

Crystalline estrone

was isolated in 1929 by two men working independently
of eac"'-' other.

Doisy and Butenandt .obtained their pure

crystals from the urine of pregnant wanen.

Since then

estrogenic substance has been isolated from mare's urine
(Laqueur, 1930), from palm nuts (Butenandt and Jacobi,
1933), from coal, petroleum and many other sources.

Its

chemical structure shows it to be basically like the
phenanthrene ring group of compounds, namely morphine,
the bile salts, ergosterol, vitamin n·, etc.

This

structure and its possible signifi ca.nee will be. consi4ered later in this paper.
A well known faot of chemotherapy, that an alcohol
is more active than a ketone, resulted in an attempt to
reduce the keto group of the crystalline estrone to
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produce a secondary alcohol.
accomplished this in 1933.

Schwenk and Hildebrandt
They obtained the substance

now known ae estradiol, the probable form in whioh the
substance is first produced within the body.

The intro-

duction of this alcohol group on the 17th carbon atom
increased the potency of the crystalline eetrogenio
substance about seven times.

However, the effect of

the product in the body was rather evanescent and so
of a.o.mp.ra'tively little clinical value.

For this

res_son workers tried to make a more lasting but
still potent substance.

Butenandt accomplished this

by conjugating the alcohol with benzoic acid to produce
a benzoate of eetradiol whioh is absorbed much more
slowly and whose effect is felt over a much longer
period of time.

This reduced the potency of the estra-

diol about one half but still it is much more potent
t'*h the original eetrone.

It is used quite

•xt~ely

in clinical work now and is known commercially as progynon-B.

The introduction of still another alcohol

group was suocei=sfully a.coompliehed but with 41.aa.ppointing results.

This substance, estriol or theelol, with

another OH group on the 16th ca.rbon atom is a rel

ively ·

impotent estrogen and of little clinical value.
In Kurzrok's recent book on the endocrines (
1937) is listed rather canpletely the action of t

rzrok,
estro-

-7genie hormone.

Eight sepo,Ta.t e functions of estrone as

determined from the administration of the crystalline
ho rm.one are listed t hue:
1. It stimulates the growth and development of the

secondary sex characteristics of the female as well as
the genital tract.

This

is beet demonstrated by the

effect of estrone on the prepubertal individuals, in
primary emenorrheas, and in the castrated individual.
(Werner and Collier, 1933)
2. The endometrium is stimulated to regenera.t.ion and
hyperplasia.

Thie occurs in the human during the

postmenetrual phase of the norma.l menstrual cycle.
It is in a sense only an estension of the first function
we list here.

(Jlari'ian and Parkes, 1930)

3. Eetrone stimulates the growth of the mammary ducts.
This seems to· be a. stimulation only to duotal growth in

•

contrast to the action of the other ovarian hormone which
stimulates lobular growth preparatory to lactation.

The

only apparent right to list this as. a separate function
lies in the fact that the secondary sex characteristics
are developed as prepubertal traits while this is cyclic
in character after the onset of the menses, occurring
each month of the menstrual epoch. (Kurzrok, Wilson and
Cassidy, 1935).
4. Estrone possesses a.n "ant 1mescul1ne" effect upon the
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male genital system.

In large doses the hormone inhibits

both the primary and the secondary sex characteristics.
That is, this hormone ie feminizing in action upon the
male individual no matter if given before puberty or
aft er.

This is not permanent act ion.

Aft er cessation

of ad.ministration of the hormone, the testes again resume
their funot ion.

This effect of estrone is probably due

to an inhibitory action on the hypophysis.

(Spurrell and

Ucko, 1938)
5. Estrone has an effect on uterine motility (deni6d by
some authorities, especially Kurzrok, et a.1_, 1936; Kurzrok, et a1, 1937) best illustrated during the menstrual
cycle or during pregnancy

wherei~

uterine contractions

tend to occur when the content of eetrin is high and
are absent or diminished when estrone is low in amount
or when 1 t is neutralized by the action of corpus luteum
hormone.
basis:

A method of contraception was conceived on thd.s

Whitney and Burdick (1936) were able to show a

definite slowing of the passage ova through the fallopian
tubes following the administration.of eetrogenio substance
into rabbits.

Since the ova are quite short lived, it

was thought that sufficient slowing in the paesa.ge of the
ova would result in senescence and non-viability of the
egg cell.

This work hae not been proven as yet, however.

(Reynolds and Friedman, 1930; Reynolds, 1931; and Bourne
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and Burn, 1928)
6. Banieohi showed in 1928 t h&t eatrone induces the
formation of •pregnancy cells• in the anterior pituitary body. (Kurzrok, 1937)
7. Verzar and v. Arsay demonstrated in 1931 that estrone
has a stimulating effect on the basal metabolic rate,
causing it to increase ten to twenty percent in the
castrated female rat.

It has no demonstrable effect on

the B.M.R. of normal males and females, however. (Xurzrok,

1~37)

B.M.R.

There is a possibility that the incret.eed

is due to a stimulation of the thyroid gland

following the stimuiation to the pituitary cells by
the eetrone.
The other ovarian menstrual hormone, the corpus luteum hormone progesterone or progeatin, is produced.by
the cells derived from the remaining tissues of the

Gra.ffian follicle after its rupture at the time of ovulation.

Whether the lutein cell• are derived from tbe

granulosa ctllle or from the theca interns. is a moo'tt
question.

The general consensus of opinion seems to

feel that the granulosa cells ar.e the source of the
corpora cells.

The distribut iob of this hormone is ,

in contrast to the estrogeni c substa.noee, rather limited.

It is produced normally

~Y

the corpora only but

during pregnancy by the placenta as well.
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The corpu.e luteum hormone was isolated by three
groups of workers almost simultaneously in eeperate
laboratories in 1934.

They were Slotta, Ruschig and.

Fels; Buten:andt; and Ylintersteiner and Allen (1934).
Its structure was determined in 1934 by Butenandt 1
et al, by converting two phy.eiologically inactive
substances of known st·ructures into the active corpus
luteum hormone.

These were stigmasterol, a sterol

obtained from soy beans, and pregnanediol,

a

saturated

divalent alcohol occuring in the urine of pregnancy.
(Allen, 1935), (Allen and Reynolds, 1935), (Allen, et
al, 1935)
The physiological action of the corpus luteum substance is listed by Kurzrok (1937) as five in number.
Mackt (1938) limits it to only two signific-ant functions for. this hormone.

Reynolds and Allen (1933) de-

monstrated in the rabbit and Knaus in 1936 that balloon.
recordings of uterine contractions showed definite inhibit ion under the influence of progesterone.

This ha•

been demonstrated to be an antagonistic action to the
pitocin :traction of the posterior pituitary and to eetrin
from the ovary.

Mac~t

also showed that progesterone

•xerts an: inhibitory action on the· uterine endometrial
hyperplasia produced by

~he

eetrogenic substances.

A

number of investigators have demonstrated that this hor~
l

.
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mone is·an inhibitor of the estrous cycle and of ovulation.

'Makepeace (1939) olaims that progestin inhibits

the release of gonadotropio hormone from the pituitary.
It is also a well known clinical fact that a corpus
luteum cyst oauaes a patient to skip periods.

The corp-

ora are the essential inhibitors of the cycle during
pregnancy.

(Hisaw, 1929) , (Hisaw, Fevol.d and Key er,

1930)
The anterior pituitary gland evolves a large number
of hormones.

The number of hormone• which this gland

produces and their apparent regfllatory influenoes on
all of the other glands of internal secretion have led
many individuals to dub this bit of tissue, the •master
gland".

It -manufaotur es a hormone which influences the

. thyroid, one or more which regulate the ovaries, an
ad.renal factor, a pancreatic hormone
eral others.

and apparently sev-

Those which are our concern are the gonad-

otropic, the thyrotropic and the adrenotropic principles.
These latter two are of interest because the thyroid
gland and the adrenal gland seem to influence the ovary
in some manner, assumed by many authorities now to be a
seoondary affect mediated by way of the pituitary gland
aa a result of that glan<!e at.tempts to regulate the
thyroid and the ad.renal glands.
The substances produced by the anterior pituitary
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which influence the ovaries are known collectively
as the gonadotropio hormones.

The number of report•

on these hormone• that have appeared in the past ten
or twelve yea.rs 1• remarkable.

'!'he first fundemental

observations were those of Smith and Engle and of
Aeoheim and Zondek in 1926, working separately.

The

hormones, probably proteins or closely associated to
a protein molecule, have not been produced in a crystalline form as have the ovarian substances.

Very

similar hormone• have been found in the placents, in
the urine of pregnancy, in castrate urine and in mare

c

serum.

These, since they can not be shown to be

identical with the anterior pituitary substance, are
oalled anterior pi'!tuitary-like substances (APL substances)
or prolan.

Perhaps the most distinctive diff•rence that

can be pointed out between the APL substances and the
true gonadotropic substance is that, though both seem
to have about the same influence on the ovary in, the
individual in whom the pituitary gland is intact, inl
those whose pituitary is absent or inactive, the APL
eubeta.noes are inactive or impotent. (Rose, 1937)
'

The gon&dotropio hormones are found in noc: other
gland of internal secretion except the hypophysis.
During pregnancy some investigators

belie~tb.at

there

ie some other source of the gonadotropic hormones,
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possibly the ohorionic villi.

Zondek has made several.

attempts to refute this conception.

However, it is

known that there is excreted during the pregnancy via
the kidneys certain substances whioh are similar to
but not identical with the anterior pituitary gonadotropio substances.

Experimentally we find that these

APL substances do not act on the ovaries of hypophysectomized animals as will anterier pituitary extracts.
Cole and Hart (1930) showed that the serum of pregnant
mares during the midperiod of pregnancy contains large
amounts of gonad stimulating substance which aote very
similarly to the a. p. gonadotropic substances.

Several

oases are on record where the use of sera of pregnant
women has been very effective where there seemed to be
a diffioienoy
of pituitary action (Hunt, 1938).
.
.
It is generally accepted that the baeophile cell•
are t......,e source of the gonadotropio hormones.

Evans and

his group (Evans, Korpi, Simpson, Pencha.rz, Wonder, 1936)
separated by a

prooe~s

of salting out three distinct

fractions of the gonadotropic group.

These were an inter-

etial cell stimulating..entity, a 1uteinizing fraction
and a follicle atimulating part which prevents hypoplasia
of this tissue and restores it after degeneration in
hypophysectomized animals. ·'!'hie action is beat seen in
the testes· where the cell• of L•ydig are regenerated in

-14a hypophyseotomized animal in contrast :to the nearby oell• of the tubules which did not show response
to thie fraotion.

The same interst ial stimulation is

seen in the ovary of these animals.

The luteinizing

fraction causes the formation of the lutein cells or the
lute1n1zing of the walls of the !olliole but it is
without effect on the interstial ·cells of the gland.
The follicle stimulating fraction causes a growth of
the follicles without repair of the interstitial cells
(the so-called •deficiency cells") or luteinization.
Upon the male this fraction causes regeneration of the
tubules after degeneration but does not effeot the
interstitial ·cells of

~be

testes.

It ·ia of inter•st to note the defference between
the male and female hypophyses in view of their simil-

.

arity of

~onadal

influence.

The anterior pituitary

of the male secretes the same hormones as the female •
.The difference lies in the fact that the female gland
produces the gonadotropic- principle in a cyclic manner
so that luteinization follows· follicle formation.

In

contrast the male gland produces a constant supply of
these hormones to the gonads •. (Kurzrok, 1937).

Pfeiffer

(1936) showed t bl!Lt the same is true in the female wtth
masoulinized hypophyses, a constant estrus is the result.

-15-

The thyroid gland and the thyrotropic hormone are
of great interest to the gynecologist i)ecause it has been
1

demonstrated olini.oally that perhape the most readily
available, the moat economio&l and the moat useful bio.;.
logical of his emoorine armement arium has been thyroid
eubatance or the thyroid hormone thyroxin.
Litzenberg, 1937)

(Falk, 1937;

Though hormonal control of the pro.,;-

mction of the hormone thyro:xin is dependent upon the.
pituitary gland through its produot ion of the regulating
thyrotropic substance,. this gland has a powerful influence on the gonads.

Thie is a secondary action mediat-

ed via the pituitary which emphasises again the central
position of this·•master gland•.
1935)

(Starr and Patton,

The thyrotropic hormone's re lat io~ to the thyroid

is almost parallel to the gonad.otropic-gonadal relation.
'l'his eimilari ty does not seem to be so strang.e when one
considers that both hormones seem to be produced from
the same type of cell if not from the same cell.

The

action of the hormone is to stimulate the thyroid to
secrete thyroxin.

Thia substance in turn is the regulator

of the metabolism of the body; it is linked with the oxidation processes of all of the body cells.

'l'he seleotive

relationship of the thyroid to the gonads is due to the
polyhedral nature of the pituitary basophile cells, a
stimulu• to secrete thyrotropic substance may also be a
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stimulus to produce other tropic eubstanoes: gonad.otropic,
adrenotropio,. etc.

The intimate nature of thie relation-

ship ts suggested by Falk'• (1937) recommendation that a11
menstrual disorders should be recommended for basal
oli•m studies as a routine

procedure~

praise thyroid eEtracts as being

metab~

Other men highly
as an

very~effaoious

ovarian stimulant even if the B.M.R. is normalfelightly
inoreaeed.

Care must be taken to avoid a thyroid reac.lt

-tion or to precipitate a toxic thyroid state. (Litzen- .
berg, 1937)
Another closely -related gland which is of note is
the adrenal glands.

Here again we see s0mnhat of a

rei'\;eration of•· the previous story,· eubstituti,ng the ·
adrenals ·for ·the thyroid g!t.and.

The basophile cell• ·

again seem to be the elaborator ·of the adrenotrppio
principle.

lie know of two adrenal secretions and sus-

pect at least one more. or some mechanisms of· these two
whioh we do not understand today.

Th~

adrenals

~ay

dtvided into two distinct parts, the medulla and

be

t~

cortex, the former produces the hormone epinephrin or
adrenalin and the latter the cortical hormone cortin.
Epinephrin is a simple amine compound related to tyrosine and the cort ioal hormone i• of unknown chemical
structure.· '!'he

a~ivity

of epinephrin hae been eetab-

liehed to be at the myoneural junctions. of the eym-

-17pathetic nervous ey_etem. I f l

••L

Of special interest

to u• is the fact that epinepheine causes contraction
of the uterue during all phases ofthe menstrual cycle.
The pregnant uterus also contracts under its influence.
'!'he cortical "hormone seems to be the e.ubeta.nce of the
ad.renal which is eeaent ial to life.

It 1• the hormone

used in Addison's disease or in individuals tn whom the
adrenals have been removed at operation.

Incidentally

it is wo;rthy of note that only very •mall biita of ad. renal tissue needs be present to satiefy the require. ments of the body.

Cortin may be used to prolong life

almost ind-efin.itely in these cases in aontrast to ·the
medullary hormone which is singultrly ineffective.
Aside from theee two hormones we also find a. definite .
inter-relationship between the gonads and the adrenals.
Precocious puberty has been observed in both male and
female in the presence Of a.n adrenal tumor or a hyperplasia. of the adrenal tissue.

Other tumors give rise

to masculiniZation of the female, the virilism syndrome.
Addison's disease is frequently accompanied by a hypolasia or atrophy of the ovaries.

The mechanism· of

these syndromes, however, is still obsaure and not well
understood.
The posterior pituitary has been shown to secrete·
at least three hormones.

.,, .. -_·,

They are an oxytoxic principle,
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·a preseox and an ant i-diuret io principl.e.

The latter

two are usually combined as one in our pxesent preparations on the market because of the methods of fractionating.

It is known as pitressin.

t ion is called pitocin or o.xytocin.

The oxytoxic porThie fraction is·

our concern in gynecology because it cause.s contraction
of the uterus under certain conditions.

Its activity

is dependent upon at least four factors; the species of
the animal, the phase of the menstrual cycle, whether
the uterus is pregnant or not, and the etage of the
gestation.

Experiments are somewhat ooatradictory to

a certain extent as to what occurs.

Beyer&1 iti'.l'eetiga.t-

ors have shown that especially in rabbite, eetrin sensitizes the uterus to the action of pitocin while pro~
gesterone tends to render the uterus refractory to the
action of this substance (Parkes, 1930).

However,

Kur.zrok, Wiesbader, Mulinoe and Wat eon (1938) made
several studies of the action of pitreesin, estradiol,
~nd

progesterone by the use of the intra-uterine bag

and on human subjects.

Significant conclusions fran

their studies are that the uterus shows spontaneou•
contractions during all phases of the menstrual cycle;
that the uterus reacts to pituitrin in a positive manner
dUTing all phases of the cycle; progesterone produces
uterine cramps during the poetmenetrual phase of the

l

l.

-19oyole but not during th+>remenetrual p~aee; and that
estradiol oocaeionalJ.y produces a rise in amplitude. r
sad tonus and may produce cramps during the first half
of the cycle without significant changes in the tracings
from the inta-uterine balloon.

It has been ahowm exp-

imentally and clinically that neither t.he hypophyeie,
tbe ovaries or a live fetus is eesent ial to the onset
and progress of lab.or.

Thie suggests at least an add-

itional factor, possibly, as suggested by Kurzrok (1937),
placental in origin.
The phenomenum of menstruation is perhaps the gyn. ecologists chief concern for aberrations of this cycle
-<

are t be chief complaints of moat of bis patients.

Long

ago this ocouranoe of cyclic bleeding was thought to be
a characteristic solely of the human being.

For the

major part of the last century it was believed to be
a characteristic only.of the primates.

Hartnan (1937)

made more careful studies and showed that bleeding begina
with the Selaohian fishes and occurs in the vertebrate
scale upwards wherever the embryo developes within a
!Jroo~

chamber at the e:xpenae of the parent.

There is some debate among gynecologists as to just·
what constitutes true menstruation.

Some believe that

menstruation is cyclic bleeding (Allen, 1935).

Another

school define it as bleeding only from a premenstrual

-20endometrium. (Kurzrok, 1937; Wieebader and Kurzrok, 1938;
Ehrenfeet, 1937)

This point is streseet\ in order to

distinguish the normal. ovulatory oyole with bleeding
from a premenstrual endometriuin from anovulatory sterile
cyclic bleeding from a poetmenstrual endometrium •. The
control

ae ~:menst ~t ion

hormonal in obaracter.

seems to be almost entirely
The hormones directly involved

are the pituitary and the ovary.

However, the influence

of other glands is evidenced by the clinical observation
that many of the menstrual dieordere are found in dyefunct ions of the t cyro id, the adrenals , and the pancreas .
The problem of the menstrual cycle is further complic'ated
by the work of Teel and Cushing (1930) .!!!nd Hohlweg and
Junkman in 1933 in which they tried to show that there
probe.bly was a central nervous eyetem sex center, proba~ly

located 1n the floor of the third ventricle.

Some

work has been done to indicate the production of antibodies or antihormonee in the body, antitheses of hormones which act to balance hornonal action (Parkes and
Rowlands, 1936; Werner, 1938).
erally accepted as yet.

This work is not gen9

Some say the apparent anti-

hormones are in reality but the

~roduction

of a refract-

oriness as a result of impurities in the extracts ueed.
Crystalline prepaxations are aadd to fail to reproduce
the antihormone phenomenum described by those using .
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impure glandular ertraote.

(Dusb&ne, et al, 1936)

Aeide from theee factor• there ia also an auxillary
mechanism present for the purpose of pregnancy and ·
delivery of the child at term.
The normal menstrual cycle 1a generally conceded. to be chiefly endocrine in nature.

It is concern-

ed w1th the development of the egg in the ovary , i te
extrusion from-the ovary, ite transportation

to

the

uterus and fertilization and pregnancy or subsequent
nidation at the end of the cycle as a. part of the
menstrual flow if fertilization does not occur.

The

rhythmical atimulue necessary for menstrual activity
comee either· from Hohlweg and Junkman' • sex center,
from the pituitary or from some gland evelving a
"bleeding hormone• (Hartman and. Firor, 1937).

Since

the pituitary pj'pothesis is our most generally accepted
one, we will use it as the starting point in the following desoripticm of the normal menses.
A rat her complete diagramat ic portrayal of the

endocrine inter-relationship during the normal menstniial
cycle was published in a paper by Kurzrok, Wilson and
Cassidy (1935)~and is presented below sligthy modified
for reference in this 41acuseion.

Broken lines indicate·

inhibitory action and solid lines stimulating action.
Quest ion marks indicate unproven hormonal act ion.
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Both the follicle stimulating hormone and the
luteinizing factor of the pitui*y gland are necessary for a oomplet e cyel.e. and no•al menstruation.

The

hormones act in rotation.btitoverlap some at the midpoint of the cyc1e or at about the time of ovulation.
Considerable evidence points to a status of equilibrium
between these two hormones at whbc.h time ovulation tends
to occur (Lase, Smelser and KurzrQk, 1938).

There 1• a

quantitative relationship existing between theee two
hormones, as well. (llarrian and Parkes, 1930; Kaufman,
1938; Parkes, 1932; Szttrkacand Kurtz, 1938)

If the

. -a3follicle stimulating hormone is present in an inadequate amount, an immature follicle which is incapable of normal luteinization results.

Inadequate

luteinization results in an inadequacy of the lutein:' hormone and in consequence a postmenetrual rather
than a premenatrual en4ometrium at the time of the
meneee.

Thie is the cyclic anovulatory sterile cycle

which some .authorities say is not a true menstruation
.

.

(Wieebader and Kurzrok, 1938).

The other extreme, an
~

.

excess of the luteinizing hormone. results ,Adue to· the
continued action of the lutein

princi~le

on the endo-

metrium, in further stimulating the endometrium to
hyperplasia of the glandular type and the inhibition
of any bleeding.

The corpus lut eum hormone renders

the endometrium and the ovary refractory to the follicle

st~ulating

hormone and so no new follicle devel-

opes and no second menstrual cycle begins.

The balance

between these two hormones is a rather delio&tely

main~

ta.ined one.
The course of the pituitary and ovarian activity
during the cycle is a very precise one.

The ovary,

first under the stimulation of the follicle stimulating
hormone of the anterior pituitary and later{&fter ovululation) under the influence of the corpus luteum frao.

tion from the anterior pituitary forms first the follicle
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and then the corpus luteum, ea.oh in turn producing
their own hormones.

Estrone, pro6uoed by the follicle,

has a stimulating effect on the endometrium to· cause
it to regenerate postme?letrually, an effect on the
uterine musculature to render it susoeptable to the·aotion of pitooin, and·upon the.mammary glands causing
a growth of the duots of the gland.

An inhibitory in-

fluence is also exerted on the pituitary (through the
sex oenter?) whereby its presence in large

~mounts

tends to restrict the product ion of· the gona.dotropio
hormone.

The aotion of eatrone is maintained through-

out the cycle to a greater or leaser degree since it
ia pr-oduced

t~oughout

the oyole, after the rupture of

the follicl.e.> by the corpus luteum.
neutralized some by the corpus

Its aot ion is

lute~

hormone, however.

The predominate hormone of the second half of the cycle
is progesterone.

Thie hormone stimulates the uterine

glands to their secretory phase and renders the uterine
musculature refractory to hormonal

stimulation~

This

hormone also stimulates the mammary lobules to proliferation.

The relative amounts of these two

hormo~ea

required to produce these changes in the oae1trated individual has

bee~

worked out by tcaufman in 1932 ( Kurs.rok,

1937) to be 40,000 rat unite of eatrone and 35 to 50
,

rabbit uni ta of progesterone. ·These amounts have also
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been checked by using them in the case of primary
amenorrhea a.nd have been found to produce the des ired results. (Kurzrok, Wilson and Cassidy, 1935)
These amounts a.re not only sufficient to bring a.bout
the menses themselves but also the full psychic and
physica.l changes involved in a normal menstrual cycle
a.a well.

This amount is not adequ&te to bring about

the development of all of the secondary sex charaoteristios, however.

With but little doubtful evidence

to sup·cort their claims, some invest igatore have
hynothetitized a "bleeding hormone or factor" which
causes cyclic flow.
di'lgreement.

The source of this hormone is in

Some point to the ovary, others to the

uterus and others to the pituitary.
The ehdometrium at various stages of the cycle is
characteristic.

Under the influence of estrone we see

a regeneration and hyperplasia, a simple growth of the
epithelium from the bases of residual fundi of the
glands lef"':; atler the nidation with the past menses.
There is also an increase in the amount .of submuoosa
as· well.

Thie endometrium is the postmenstrual hyper-

plast ic type.

The glands a.re typioally straight tub-

ules lined with ouboida.l epithelium and not showing
secretory activity.

Under the influence of progest-

. erone, the glands are stimulated to further growth and
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to secretion·, becoming markedly tortuous and filled
with secretion, the typical premenstrual endometrium.
Near the end of the cycle, due to some· unknown st imulus, the endometrium begins to slough and menstruat 1on·1-ocmurs.

An anovulatory cycle possesses only a

poetmenstrual endometrium. at the time of the menses
due to a laok of the progesterone et imulating phase
of the cyole.
'i'he effect of the_ sex hormones at various periods
of the life cyole is a very interesting sidelight of
the .. aotivity of the. hormones.

Probably the earliest

differentiating processes of ear1y cell: life, the
motivating force is not endocrine in nature.
mentation and diferent iation proceed

The seg-

aooo~C11ng

to some

·foreordained pattern possibly due to some "germ plasm
force", an l:lD:knOWn quality and quantity.

The whole

process is as regular and regimented as the

~ess

parade of crack drill troops; beautifully precise throughout.

The developm·ent of the accessory sex organs, the

uterus and the breasts most not eably, are apparently not
on the .basis of endocrinology though they show a very
early sensitivity to endocrine influence.

It has been

noted by a number of clinicians that the uterus is larger
at birth than 1 t is shortly afterwards.

The withdrawal

of the influence of the maternally derived hormones may
also bring about a single pseudomenstrual bleeding a week
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or so after birth, the ao-called "non-menstrual genital
hemorrhage of the newborn".

The mammary activity of

both sexes at birth and whUe at brea.et has been an obaervat ion of long standing and a very good illustration
of the sensitivity of the infantile tissues to the sex
hormones.

Thie aot ivi ty

of the breasts. is moat pro- .

nounoed during the· second week postpartum,. varying· in
.quantity from a few deops to fifteen to twenty oubio
centimeters.
mil~".

It is known more commonly as "witch:"•

The pituitary hormone prolaot 1D. has· not been

demonstrated in the infant but the APL substances and
estrogenic substances are found in the urine and blood
of infants during the first few days of

life~

(Boule,

1938)

Little is known of the ·importance ·of the ovary during the prepubertal years.

We do lmow that the follicles

mature to a oertain stage of deyelopment. and that at least
some estrone is produced for a long time, even several
years before the actual onset of puberty.
ly parallels a

s~il.ar

This apparent-

awakening of the pituitary gonad-

otropic hormone activity in the baso'phUe cells of the
an~erior

pituitary gland.

The various sex and secondary

s.ex organs are selectively sensitive to the various hormones.

Thie is demonstrated by the ooouranoe of precoc-

ious puberty and menstruation in 9hildren with granulosa
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cell carcinmna and vaginal epithelial hyperplasia like
that of puberty following the therapeutic ad.ministration
of the estrogenio eubstanoes in the treatment of infantile gonorrheal vaginitis. (Lewis, 1933; TeLinde, 1938;
Novak, 1938)

Granulosa cell tumors are developed from

rests of redundant· granulosa tissue left over in the
early developnent of the oophorogenio apparatus of the
ovary.

In the same manner the arrhenoblaetoma, masou-

11niz 1ng tumors manifest themselves by their endocrine
activity.

They may develope from the persistent rem-

nants of the masculine scaffolding which precedes chronologically the formation of the Mullerian apparatus.
In oonolusion we .may say that, though the primary
~

..... -"'

sex differentiation is due to the initial germ impulse,
the prooees from there on out is due to endocrine aot iv1 ty.

The gonad.a under the influence of the pituitary

bear the chief ;burden of lµl.folding the secondary sex

-

oharaoteristios as well as developing the genitals themselves.

Though we know little quantitatively of the

inter-play of these two - :aotors 1 the knowledge of their
a~ivi ty

has al:Lowed the gynecologists to explain more

logica:Lly and physiologically the varying degrees of
sexual reversal seen in hum.an beings and lower animals.
This is in contrast to and a step above prior times when
explanations were only on an anatomical basis which was

-29applicable only to the well developed oases with marked
structural

changes~

Now· we can appreciate the less well

developed cases of . sexual reversals;
appreciate that
.
an individual with testes may be dormantly feminine and
the contrary as well.

On a purely endocrine basis we

may now explain the viriliem syndrome of the adrenal
cortex (androgenic. tissue·?); tumors of the pituitary,
the so-called Cushing Syndrome; and tumors of the ovary,
the arrenoblastomas.
Little is ~own of th,repubertal funo1ion of the
ovaries.· The basis of our knowledge is based for the
most pe.rt on the negative
tions.

~videnoe

furnished_ by castra-

These oases are rather rare 1n the female in

contrast to the male.

The only effect noted in humans

to date las been a failure of appearance of the menses
together with a disproportionant skeletal growth like
that seen in early ma1e castration that produces oµr
•.lmUOh8.

Long before the first menstruations , maturation of
t be foll iolee and the product ion of estrone are noted
by histological sections and hormonal determinations done
on the blood.

The usual sequence is f iret an incomplete

maturation and then graduated degrees through partial to
complete maturation without ovulation but possibly with
periodic bleeding and finally full maturation with ovul-
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ation followed by formation 6f the oorpus luteum and
. the beginning of the ovulatory type of monthly flow,
the true menstrual period.

There. is little doubt but

what many girls ovul.ate with the first menses and some
even before as adjudged from the reports of pregnancy
immediately after the onset of the menses. or before the ·
first periodic flow in a f-ew oases.

All evidence, how-

ever, points to this as an except ion rather than the
rule.

Biopsies of the endometrium of the uteri of gi%ls

who are just

beginn~~o

have- a

mont~ly

flow show a- .post-

menstrual type rather\than premenstrual, indicating an
anovulatory oyole with no format.ion of a corpus luteum-.
·This indicates, as we stated previouly, the periodic
bleeding which s.o many authorities do not wish to call
true menstrual flow.

The flow may be quite normal in

amount· and regular in rhythum but more oft en there are
irregularities of either the amount of flow or the time
interva.l ... of the flow so that ol1n1oally these oases frequently present themselves as instances of functional
bleeding of mild or severe grade as the oase may be.
Further evidence lies in the physiological sterility
of most ohildbrides as those in India.

Studies made in

the Berlin Frau:anklinik by Mikilicz and Krausoh a few
years ago on a large number of young primigravidae fran
a standpoint of their cohabitational hfetory in relation
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to their feau.ndity show a eurpria1ng amount of sterility for as long as several years in many cases in spite
of an active. sex life from

~uberty.

We. eee the same fundemental •tapering off 11 at the
other end of the aex period of women_, the menopause.
Here it has been demonstrated iY' endometrial biopsy a
tendency to a hyper-estrinizat ion .due to failure of
ovulation to occur.

Functional hemorrhage, for thEtt

matter, has been shown to occur at almost any age after
puberty because an anovulatory cycle "is a rather freque
ocourance through the lives of most women.
ly unaccompanied by any abnormality of bleeding or othe
.,

__

..

symptoms so that the

indi~idual

is unaware of which cyc es

are anovule.tory and which are not.

It has been stated b

some that the interval following an anovulatory cycle
tends to be a long one in contrast to the anovulatory
cycle which tends frequently to be shorter.

Kurzrok,

Lase, and Smelser (1937) noted in lactating individuals,
too, a predominance of anovulatory cycles for a variable
period of time.

The record in several patients showed

more than six successive anovulatory cycles in 1nd1v1due. s
producing milk.

Thia is said to hold true in from 55% to

60% of the eyol.es during lactation.

Such men as the abo

three, Lahn and Riddle (1936), Dreel (1935), Kurzrok and
Wilson (1936) and others have used this as a basis for
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attempting to set up a physiological method of hormonal
contraception.

Their work is still .in the experimental

stage;
Though we believe that the endocrine mot 1vat ion for
ovulation is probabl.y the pituitary,· the association
with lactation also points to a possible inhibitory factor in the

.
eeoreti~g

.

breast or, more remotely, an accel-

erating factor 1n the quiescent br.eaet.

The ihhibitory

factor was demonstrated experimentally in mice and rate
by Dresl (l.935) and later confirmed by Riddle (1936).
They showed tb.U prolaotin, the pituitary h_ormone et.imulating lactation, is.

c~pable

of producing_ a tempo1'ary

suppression of the ovarian cycle activity.

Clinically

we see three achoo.ls of thought as to the cause of failure of the follicle to perform as it usually does.

Some

treat these anovul.atory sterility and hyperestr1nization
cases as being due to a lack of the follicle ripening
factor (the anterior pitu•tary follioular hormone).
Others consider the l.ute1niz1ng factor of the anterior
pituitary to be the deciding endocrine.

Hisaw and hie

coworkers (1935) believe in a balance of these two factors.

These investigators have, by varying the proportion

of .these two gonad.otropic elements, been able to induce
ovulation in non-ovul.ating· monkeys.

The therapeutic value

of t hie work is of. course suggestive onl.y because quantities are not only species variable but also somewhat var-
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iable form one individual to another.

The accepted

therapy at the present time is the use of one or the
other of the gonadotropic eubstancee· at or near the
calculated time of ovulation with subsequent satisfactory results shown by the presence of a premenstrual
endometrium upon curettage.

Some of these nsatisfaot-

ory" results may be false positives in that not all
menstrual cycles in the same woman need be anovulatory
and perhaps the cycle under teeatment was a normal "
rather than abnormal oyole. (Novak, 1937)

For a per-

iod of time near the time pf the menopause, the tapering off of the gonads make such therapy a very variable
quantity and of doubtful value.

Some oases possess

euffic•ent of the hormones that only a very small amount
needs to be supplied artificially to produce the desired
results.

Other oases where the menopause is more ad-

vanced, larger doses are needed to

~roduce

the same

result and tide the patient over until an endocrine readjustment has been made.
The following discussion of gynecological problems
·.

from an endocrine standpoint wi-11 be on the basis of
symptomatology; the cause .and treatment of the pat iente
presenting symptom such as an amenorrhea, dysmenorrhea,
menorrhagia, etc.

Diagnosis and treatment are based on

the bGe ic endocrine pattern heretofore outlined.
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Perhaps the most common of the fema.le complaints
in relation to the menstrual cycle with which the gynecologist muet deal ie the problem of amennorrhea.

It

may be defined as the absence of menstruat.ion either
after the meneee have once begun (secondary amenorrhea)
or a failure of the menses to 'tegin (primary· amenorrhea).
The endocrine basis of menstruation limits this symptom
to a malfunction of one of three glands or a combination
of any of these.
and the pituitary.

These glands are the ovary, the thyroid
(ll'rank, Goldberger, Salmone and Fel-

skin, .1937; Falk, 1937)
The normal amenorrhea of the menopause and the prepubertal .periods is most OPrtainly due to a
ian activity.

l~ok

of ovar-

It is no doubt an expression oi the begin-

ning and the completion of the life span

~f

that gland.

Premature ovarian failure is essentially an early menopause characterized by an amenorrhea, disappearance of
eetrin in the blood and a persistence of the pituitary
gonadotropic hormones.

At times we also see concomitant

vasomotor and subjective menopausal signs.

Curettage

reveals an atrophic uterine endometrium.· This amenorrhea is usually intractiable to treatment; one might say
that it represents a short lived ovary.
relief especially in the young

A possible

individual~

from the

vasomotor and other subjective symptoms lies in ovarian
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tran•plantation.

Kurzrolt, Wilson and Cassidy (1935) in

a study of primary and secondary amenorrhea treated with
large doses of estrogenic eubatanoe, found eetrogenio
substance to be most effective in secondary amenorrhea
where they were able to bring about regular cyclical
bleeding after the administration of aaseive doses of
eetrogenio substance (up to 200 ,000 R.U .). Their study
also confirmed Kaufman's findings that 40,000 R.U. of
estrogen~o

..

substance was neoessary to bring about all

of the phenomena of the menstrual cycle., orga.nic and psychic.

In this group of primary amenorrhea we have the

type which is without evidence of.pituitary.or thyroid
disorder and in which the only clinical conclusion is
that of 1J1pogonadal funot ion.

Perhaps some of these are

capable of normal activity if only the other associated
endocrine stimulation were sufficient.

That is, suffic-

ient pituitary st·imulation would result in ovarian activity.

Primary amenorrhea of this type usually show a

hypoplasia of the genitalia and an absence of or an underdevelopment of the secondary sex characteristics.

Therapy

in these oases is frequently of little ultimate therapeut io gain.

In some oases thyroid a4ministered will increase

t be gpnadotropic secret ion to the t hreehold necessary fer
ovarian activity.

Cessation of leatment is usually fol-

lowed by a cessation of the bleeding and a regression of
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the other characteriet ice that were brought about by
the treatment.

Since there is no· ultimate gain, and

since it is not a life aa.v1Iig measure, many authorities
do not consider such treatment worth while.

Kurzrok

(1937), however, believes that such treatment is desirable because it is a step in the right direction.

That

is , it is an attempt to restore the body to its normal
state of functioning and it does make these patients
more comfortable, perhaps more psychically than pb¥eically.
Kurzrok apeaks hopefully of the possible preparation in
the near future of more potent glandular preparations and
preparations which will be absorbed slowly over a period
of time.

Thus, these patients would be much like our

diabetioe at this time.

The mild cases of hypogonadism

of short duration are frequently permanently cured with
the use of thyroid. (Litzenberg, 1937)
That the pituitary may be the cause of an amenorrthe. fact that Frolick's
hea is readily demonstrated by
.
Syndrome (dystrophia adiposogenitalis} contains as a
component an amenoerhea.

However, not all pituitary amen-

orrhea are of this adipoeogenital dystrophic type.

As a

·rule, hypofunction of the pituitary gland does usually
produce an amenorrhea, especially in those who have never
menatruated.

These primary amenorrheas most commonly show

a concomitant growth d.isturba.nce of the skeletal system.
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Since the pituitary is the whole driving force behind the
genital tract, hypofunotion of this gland will manifest
itself very frequently as varying degrees of genital inadequeoiee.

There is usually an absence of the second-

. ary sex oharacteristios or at least a retardation; there
is a pereistaBt absence of estrin in the urine because
the pituitary is not stimulating the ovary to follicular
formation; and there is a laok of or a diminished amount
of gonadotropic principle excreted in the urine.

Admin-

istration of estrone or of gonadotropio substance (not
APL substances) to these patients will bring about temPorary relief but, like the completely nonfunctioning
ovary, it is not permanent.

(Kursrok, 1937}

In oases

ef

seoondery amenorrhea attributable to_ pituitary hypofunction its response to therapeuees is
the complete types.

mo~e

promising than

In all cases of amenDrrhea, preg-

nancy or recent ar,ortion must be ruled out.

Perhaps the

Friedman test is the· clinician's most accurate laboratory
method for this.

Estrone, thyroid substance or the gonad-

otropic principle administered to these indi vidusJ.s frequently Will stimulate the pituitary basophile cells to
aot iv it y and, since the ovaries are normal, cyclic ova
production will again be resumed.

In the use of the APL

substances and of the gonadotropic hormones, Roes (1937)
deplores their indiecriminant use and advisee against it.
It these substances are given, avoid the commonly made
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error of not giving enough of these substanees.

Roes

blames many of the clinically poor results from these
hormones to inadequate doaage.
One of the usual component e of a hypothyroidism

.

(myxedema) is an amenorrhea.

This is no doubt due to

the ,fact th.at the thyroid gland is not secreting the
I

-

necessary amount of thyroid substance either because
of a deficiency of thyrotropic principle from the anterior pituitary or e. lack of response on the part of
the thyroid to normal thyrotropic stimulation.

The in-

adequacy of the thyroid is reflected via the baeophile
cells of the adenopi tuitary as a

hypofun~ion

ovary, secondarily, and an amenorrhea.

of the

An apparent

antithesis to this is seen in cases of hyperthyroidism.
Here, too,. we frequently see an amenorrhea.

This may

be rationalized, however, when one considers the forces
of compensation that we find 1n the human body.

G~nerally

speaking, small amounts of hormonal secretions injected
into the individual are

etimulat~g

in nature while large

amounts tend to act as substitutive sources and so depress
the activity of the gland cells •. (Dacosta and Carlson,
1933)'

Whether this is a direct suppressive act·ion on the

gland or not is not known.

Rat her it is felt that it is

probably a reflea control of the gland mediated via the
"master gland", the pituitary.

That is, as 1n hyperthy-

:
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roidism, the large amounts of the hormone thyroxin produced tends to suppress the basophile cells of the

pit~

uitary in an attempt to reduce the amount of thyrotropic
principle formed and so reduce the activity of t ha thyroid.
As the basophile cells slow down on the formation of the
thyrotropic substance, the gonadotropic substances produced by the same sells is also dim1nlehed resulting in
a deficient stimulus to the ovary and an apparent amenorrhea.

Thie amenorrhea may be either of the primary or

secondary type, usually the latter since most oases of
hyperthyroidism occur postpuberte.lly.

Treatment is of

course along the lines of restoring the normal endocrine
balance, reost easily done here by correcting the thyroid
function.

'l'hyroid substance or thyroxin is used for hypo-

thyroid states.

It must be remembered

tha~

the hypothy-

roid state does not nefd to be a full blown myxedema and
that it may not even show a significant change in the
B.M.R. reading&. (Haines and Mussey, 1935)

Hyperthyreid-

ism which does not yield to medical treatment of course
comes under the surgeon's care for an extirpation of most
of the gland.

(Kurzrok, 1937; Falk, 1937)

The etiology of dysmenorrhea, our next cons iderat ian,
is ·aa id to lie in the development oi' the uterus (I eratl ,
1936).

The development of the uterus in turn is under

the control of the hormones and the central nervous system.

Additional factors are seen in the nervous makeup
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of the individual and the const ~tutional type.

The thin

dynamic and "high strung" person seeme to be more prone
to discomfort at the time of the menses.

The emotional

background is also seen as a factor in the frequently·
seen too literal interpetation.of the t\e •sick period•
by the woman.

Young women are frequently taught t1Jat

the period of menstrual flow is. a normal siok time for
females ant

that at that time she is supposed to be 111,

weak, fatigued and very susceptible to all sorts of ailments.
Primary dysmenorrhea is our .concern from the viewpoint of endocrinology bees.use almost all seconde.,ry
dysmenorrheas, those that have their inception after
the nomal onset of the menses, is on an anatomical
basis and is seen most often following childbirth-trauma.
Novak and Reynolds (1932) consider the cause of dyemen~
orrhea to lie in an imbalance in the estrin-progeaterone
ratio; they believe that an increaee in theelin (eat;-in)
and diminished amount of progesterone ie the cause of the
pain.

Moir (1934) carries their concept a step further.

By a.ayetem otalloons in the uterine cav"ity, he profeseee to have shown that the sensation of gees.test discomfort
coincided with the peak of a uterine contraction.

Aleo

each peak is marked by a disappearance of the uterine arterial· pulsat iona causing an area of iaohemia and pain much
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like that that we see in angina peotorie and intermittent olaudioation of a part.

.Kennedy (1932) be-

lieves that dysmenorrhea is associated with degeneration in the Frankenhauser'a ganglion due to an estrin
deficiency.

Therapeutics in the latter concept is of

course the administration of eetrin.

In the first

hypothesis, einoe the eetrin is believe to be in excess
and the hormone present in diminished amounts is progesterone, this hormone is the logical therapeutic
agent.

B"oth of· ·these schools of thought are combined

by those who stick to the middle path e.nd say it can
be either or a little of both.

These use whole ovar-

ian substance or the gonadotropic hormones from the
pi.tui tar.y. gland.

All .three schools claim about the

same proportion of ouree or relief of the symptom.
(Novak and :Riynolde, 1932; Novak, 1933; O&mpbell and
His~

1936; Elden and Wilson, 1936; Kotz and Parker,

1937)

Lachner, Krohn and Soskin (1937) have done an

extensive study of :the problem of dysmenorrhea.

Using

an intrauterine bag, they claim to have shown tha.t
estrogenio aubstan.ces augment uterine contract ions and
progesterone inhibits. (Krohn, Lachner and Soekin, 1937) .

.

Kurzrok {1937) emphatically denies that this occurs and
critioiaes these men's work on the baeie that the intrauterine bag stimulates the uterus to contract to a degree
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tbat renders their conclusions inaccurate.

However 1

these ii.'ree workers have applied the endocrines in
their oases, not by rule of the thumb but rather on the
basis of tht!r physical findings with rather good
therapeutic results.

They divide their dyemenorrheic

patients into two types.

In the first are those who

indicate the presence of an exeees of estrin by virtue
of havi.ln15 a large well developed uterus with

moderat~

to long contractions, as revealed upon bimanual pelvic
examination and the intrauterine b,ag.

These patients

were relieved by the use of progesterone.

In those

individuals in which they found a small hypoplaetic
uterus which shows little or no contraotility are treated with estrin with good results.

It has been observed

clinically for a lo rig time that pregnancy frequently has
a salutatory effect on primary dysmenorrhea, probably
because of the "shook• to the endocrines ae they a.djuet
for the pregnancy and then readjust afterwards for tne
nongravid state.
The symptom of excessive bleeding, either at the
usual t 1me of +the menses of between the periods may be
due to an organic or. a functional ·condition.

In the form-

er, the endocrines are of no avail as far as therapy is
concerned for the conditon shows anatGmioal changes irreversable under the influence of any of the endocrinee.

The
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only part these substances play in the lesion is perhaps prior to their development; an etiological factor
which we will consider later •. Th'd functional type of
bleeding frequently respond• to endocrine therapy because 1t is

usual~

due to an ovarian hypofunot1on,

(Wilson and Kurzrok, 1936; Burch; et al, 1937). It hes
been shown a number of times by various El.uthorit ies
that the endometrium reflects proport ionatly the severity
of the hypofunction cf the ovary.

Therefore biopsy is

indicated in these oases
not only as an ind.ex of the de,

.

gree of ovaian failure but also to differentiate.it from
an organic lesion.
"Menorrhagia or metrorrhagia may be seen ·at almost
any age,

In the adolescent irregular bleeding. is prob-

ably due to an endocrine
time of the

immatur~ty.;

e~tablishraent

a failure up to ·that

of a normal endocrine balance.

These·individuals almost inva.ria~ly correct themselves
spontaneously but may need aid perhaps more peychologioally than physically.

These profuse bleedings of the ad-

olescent are usually caused by a hypertheelinism with a
typical ·hyperplastic anovulatory endometrium.

Admin-

istration of progesterone for a number of days, usually
about five, prior to the time of the expected period will
frequently peroipitate the
of fun·otion.

o~ary

back to its normal rhythm

Ohute (1936) makes the statement that an lhn-
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euffi ciency of the anterior pituitary is probablJ' the
cause of most of the disorders of the other endocrines
and may even lead to a secondary hypogonadism
male and the female.

~n

the

Bur oh, et al ( 1937) have ltld

rather good results with the use of progesterone in
oases in which the ovaries have started activity.
The middle age group is
gr~p

~Y

far the biggest clinical

with the excessive gleeding syndrome (Falk, 1937).

Perhaps the most striking form of functional menorrhagia is the.t in which we find a glandular cystic endometrial
hyperplasia, the so-called 11 swies cheese" endometrium.
Shroeder in 1912 wae·the first to emphaeime the correlation between endometrial hyperplasia and the ovarian
changes characterized by an absence of coiiora snd the
presence of follicular. cyst e.

It hl\e e inoe been demonf'o

etrated experimentally that partial distruction of the
ovary may cause an alternation in the estrous cycle so
as to produce prolonged stages of estrus and glandular
cyst io hyperplasia. of the endometrium.

The same thing

has been 'observed in partially hypophysectomized animals
as well.

Payne (1937) analyzed a series of 534 OS-see and

attempted to dem0nstrate that a failure of correlation
between endometrial hyperplasia an4 functional bleeding
existed. ·Criticism of his paper by severa.J. men emphasized the lack of standardization of the term endometrial
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hyperplasia.

A loose application of the term bai led

some workers to consider all growth of the endometrium,
even that of the normal ovarian cycle, an edometrial
hyperplasia.

Burch, et a1 (1937) brought out that the

evidence is almost conclusively a.n indictment of the
hypofunctioning ovary as the immediate ca.use of the
functional menorrhggia and metrorrhagia.

The degree

of hypoactivity is ··reflected alnJOSt ciuantita.tively in
the uterine endometrium.

cases <>f funct iona.l bleeding

which show rathe+u11d symptoms and in which we can deonatrate a more or leae normal endomet:rium is indiative
of a first degree ovarian failUJ9e; severe bleeding with
a characteristic glandular cystic endometrium indicates
a second degree hypo-ovarianism; and bleeding or· ,the
opposite, an amenorrhea, ie found in cases with an
atrophic endometrium as a reeul t of a third

d~gree

( ocmp-

letel ovarian failure.
In almost al1 cases of functional bleeding we see
evidence of other endocrine dieturgance as well, no matter
the degree of ovarian failure.

The glands which are

usually involved are the triad, thyroid, pituitary and
ovary.

The sum and substance of the whole matter is that

metrorrhagia and menorrhagia are but manifestations of an
ovarian hypofunction, which may be in itself primary l)r
secondary to disease or dysfunction of the pituitary, the
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thyroid, or to some constitutional disease affecting
one or more of th4endocrine glands.

The mioroeoopic

examination of the endometrium ·is our yardstick of
the severity of disturbance of the ovarian function.
The principles of treatment as advocated by Kurzrok; Burch, . et e.1; and others may be
number.

l~sted

as four in

First and foremost is a correct diagnosis.

Then it is necessary that
crine lesion.

~e

treat that specific endo-

Beat results in the past h.ave been had

with hypothyroidism, or with the administration of thyroid substance even where the B.M.R. is normal (Falk,
1937; Litzenberg, 1937).

The third car~inltl point is

the eradication of any contributory factors ·of ill
·health.

The final resort is surgel)i

Before using this

means, one must be certain that the surgery elinlinatee

~

t'19 primary pathological condition if the patient .is to
be au.red.
··The consideration ofthe climaterio is an important
one.

This period marks the end of the sexual epoch in

woman that was initiated at puberty.

In fact, it is

probably the refer•al of the process which we find marking the change from adolescence to sexual ma:lurity.

KuTz-

roi: (1937) states that it eeeme to be a cessation of the
pituitary-ovary~uterine

relationship,

The etiology is

therefore dependent on one or a oomvination of tnese three

--
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structures.

Ultimately, of course there is always an

ovarian failure.
The menopause. is popularly conceived to be an abrupt
process marked by an amenorrhea.

This is an error.

It

is in reality a very gradual process beginning perhaps
about the middle of ·or the latter part of the fourth
decade of life as a slight diminution in the flow and
perhaps without a conscious manifestation to the individual.

The whole process proceeds to the actual cess-

ation of the menses.

Howe~rer,

the number of oases On.

record of pregnancy after the onset ct the menopausal
amenorrhea indicates that the amenorrhea is no absolute
criterion of ovarian inactivity.

In short, the meno-

pause consists of an internal unconscious mechanism
which is menifest ·somewhere in its course as an amenorrbea.

Other presenting symptoms seen in varying degree•

are neurovaecular symptoms, observed in almost all patients to a greater or lesser degree as hot flushes,
sweats, palpitation, sleeplessness, nuilbness or tingling
of the extremitiee and sensory neuroses especially of the
throat; pelvic atrophies, perhaps most frequently an
associated pruritue vulvae; and disturbances in other
glands of internal secretion.

About one third of the

patients show weight increase of twenty pounds. or more.
About 10% have joint symptoms.

Languor and fatigue are
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are common complaints.

There is frequently a thyroid

dysfunction at this time with a tendency to hyperrather thank hypothyroidal state, usually.

Novak

(1938) claims that the vasomotor symptoms are the only

ones that can clearly be attributable '6o hormone f.laladjustment.

The other symptoms may possibly be pro-

duced secondarily as a resnlt of this imbalance.
(Wiesbader and Kurzrok, 1938; Donald, 1938)
When the en4oor ine glands are pi otured as a balanced group, it is readily seen that the lose of one ~.
of the group may upset the balance to a great er or . .
lesser degree and necessitates a compensatory readjustment of these glends to a new state of balance.
Watson, Smith and Kurzrok. (1938) and Kurzrok and Smith
(1938) seem to have demonstrated that the ovarian fail-

ure is due to inherent qualities· which. ·render the ovary
refractory to the gonadotropio substance from tbe pituitary.

Thie lose of responsiveness is gradual in onset,

culminating usually at about the forty-fifth year in a
completely non-f1Jnotioning ovary.

T!·is functional limit-

ation of the ovary has been demonstrated clinically to
exist not only at this end of the sex epoch but also
at the other end.

Here, too, it is a graduated process

of ovarian refractoriness progressing, however, frcm an
insensitivity to the normally sensitive ovary of the
menstrual oycle; the menopause in reverse, eo as to speak.
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The paint of least response to stimulation at this end
of the cycle 11 at aboutthe age of six montha.

Great-

est sensitivity to the gona.dotropio '3Ubsta.noes is eaid
to be during the third decade of life.
as a result of a number of

att~pts

Merioard (1936}

to graft ovaries

from young girls to elderly individuals with a large
· number of failures to "take", believes that there must
be some additional faotor.

He suggests a general senile

diathesis or perhaps a laok of adaptability in the more
elderly individual.
In about 85% of the women, the symptoms are not
severe enough to force them to oonsult a physician.

The

symptoms of the biggest portion of the remaining 15%
which are seen as patients by the profession are rather
self limited and usually respond readily to some mild
fom of therapy.
failure,

Since the procese is one of ove.rian

the~qgical _course of therapy ie the administra-

tion of estrin or whole ovarian substance (Macleod, 1938}.
Kurzrok (1937} recommends a combination of the two.

He

olaitns that the symptoms are usually relieved very prompt-·
ly or are at least helped.

Best results were seen in hle

oases in those individuals who have a ocmplete menopause,
ie. complete cessation of the menses.

Pratt and Thomas

(1937} bring out in their paper the marked psychogenic
factor in this syndrome.

In a series of ca.see whiOh they
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considered well controlled, they reoieved almost an
equally good result with ·a placebo as with the administration of the endocrines er sedation.

Contemporary

comment on their paper tended to indicate a majority
of opinion that, though a marked psychogenic factor
is probably present, better results are seen in those
patients that recieve ovarian substance rather th8.n
sedation or placebo, other things being equal.

The

administration of the hormones are only for· relief of .
the distressing symptoms and a tapering off should ·be
followed as much as possible.

Novak_· (1938) in a· recent

paper states that the results from estrogenio therapy
for t be

men~paueal

symptoms are very variable,· rarely

brilliant but usually satisfactory.
The only tumors of the ovary which have endocrinologi cal importance are but twa in number.

Both of

these are relatively uncommon but their chraoterietic
endocrinologioal symptomatology justifies their being
included here.

Since these two tumors are best class-

ified by the character of the endocrine produot excreted,
fhey are termed estrin producing .tumors and maeculinizing tumors or arrhenoblastomata (Novak and Long, 1S33;
Novak and Gray, 1936).
Arrhenoblaetomata (lovak, 1938) develope frOm undifferentiated sex cells near the hilum of the ovary,
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remnants of the\nale cell• which were present when the
ovary was an undifferentiated gonad in the embryo.

Thus,

when these tumors suddenly begin to grow, they usually
produce male oharact
er 1st ice.
.,

That is , we have the

viriliam syndrome: the breasts atrophy, the clitoris
enlarges, and the hair distribution is of the masculine
type.

This is very interesting 1n vin of the fact

tht.t, though androgenic preparations inhibit the anterior
pituitary, estrin has a much greater inhibitory power
and these tumors frequently develope in the face of
both of these hormones. (Nelson and Gallagher, 1936;
Wolfe and Hamilton, 1937)

·C

Thie syndrome (Falk, 1937;

Varangot, 1938) is present in three types of tumors:
arrhenoblast omata of the ovary, the. so-called Cushing
syndrome

desori~ed

for tumors of the e.nterio& pituitary,

and tumors of the adrenal cortex.

The Cushing syndrome

is the result of an overproduotlon of one of the pi tuitary hormones, probably adrenotropic whioh stimulates
the androgenic tissue to inore<'eed activity and thereby cause the masculinization of the individual.

The

aocompaning glyoosuria, obesity, etc. of the Cushing
. syndrome is no doubt the reeult of involvement of the
intra-mednlle.ry oonneot ion' or possibly to stimulation
to production of other hormones by the pituitary.

The

male sex hormone that may be a.ct ive in the arrhenoblast-
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omata can arise from the tumor cells, from the·· medulla
of the ovary which has potential masculinizing powers,
or fo.,_..m a referred et imulation of androgenic tissue in
the adrenals via the pituitary or perhaps even directly.
It must be stated, however, that no one hae been able
to demonstrate in thepresence of an arrenoblastoma an
excess of the male sex hormone.

Hormonal studies on

these patients are of doubtful value since both the
male and female hormones are commonly found in the urine
of both sexes (Novak, 1938).

Therapy is distruction of

the tumor either by excision or with roentgen ray.
The estrin

produci~g

ovarian tumors are either

granulosa cell tumors or t heoa cell tu.more.

The f iret

is composed of typical granulosa cells while. the latter
h&e a connective tissue-like or theo&-like character.
Geist and Gaines (193 8) speak of the. presence of doubly ·
refractive fat in large amounts 1n these tumors as
oha.raoteristic.

Though pathologically

differen~,

these

tumors are clinically identical because they both evolve
the estrogenio hormones which are responsibae for the
clinical picture.
common.
grow

The granulosa type is by far the more

These islands of embryonic cells may start to

and function at any age, causing symptoms of hyper-

eetrinization.

About ten percent are found 1n individuals

before puberty, forty-two percent during aot ive eex life,

. -sa·and about forty-eight peroent poet-menopausal.

The

theoa .cell type is more prone to ocour after puberty
and the menopauee
Falk. (1937).

t~n

the true granulosa cell type,

The origin of the stimulus to grow is

not known, but it is generally cone idered to be of
endocr1nolog1.oal origin, more probably the pituitary.
Both of these tumors produce.large amounts of theelin
(estr:lb) and clinically present a picture due to this
hormone production.

The symptoms are dependent some-

what on the age of the patient at the time that the
tumor begins to function.

In young girls, the second-

ary sex characteristics appear and the uterus enlargeea.nd they begin to menstruate.

Tn the childbearing age

the symptoms are masked by the normal menstrual aot ivity
and the only evidence o:B an abnormality is an excessive
menstrual· flow.

The diagnoe is of a granuloea cell tumor

during the active sex life of the individual is very
frequently missed on this account.

After the menopause,

the symptoms are again the presence of anaooountable
bleeding.

Caro1nomatous degeneration of the uterus must

be ruled out in all oases of bleeding. (Meeker and Loc&lio,

1938)

Removal

·O~

the tumors by eaoision or by roentgen

ray· results in a prompt regression of the ser che.raoter...
istios developed as a result of the tumor.
isA"rela ti ve benign

ne6plasm~

Thia ti.imor

though some. reports have

-53-

been made of malignant activity of thie type of growth.
(Norris; 1938)
One of the most startling and effaoious uses for one
of the ovarian secretions ha.e been established during the
past five or six years.

That is the use of estrogenio

preparations in the treatment or"aginitis, gonorrheal
vaginitis in children and senile or infectious vaginitis
of adults past the menopause.

Lewie (1933) was the first

to use estrogenio substances in the. treatment of vaginitis.
He used the hormone on little girls having gonorrhe•l
vaginitis with resulting startling changes in the epithelium of the vagina, change in the character of the
vaginal secretions and prompt alleviation of the condition.
Gonorrheal va.gini tis is one c·f the most common
affections of little girls, expecially during infancy
and the first five years of life.

Athough seldom ser-

ious, the disease is tedious and a source of great
an,siety and unwarranted mort i:fication to the parents.
It may also serve as a eouroe of secondary. infections,
especially the eyes.

It seems to be selflimited in

character and seldom if ever leaves any permanent aftor
eff eot e.

Recovery is almost always complete before the

age of puberty:

the disease is seldom if ever carried

over into the period of puberty.

This condition is im-

portan~not because of any serious nature of the disease

'!
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•

but rather because of its high incidence in institutions
where the increase in morbidity is significant.
In 1933, Lewie

publish~d

his article which revolu-

t ioniz·ed the treatment of this condition.

He conceived

the idea that, since gonorrheal vaginitie is not seen
after. puberty.,

the'~

infect ion must in some manner be

altered by the changes that occur with puberty.

It was

common knowledge at that time tM the prepubertal vaginal mucosa is but four to ten cells in thickness 1n
contrast to the pubertal vaginal lining which is twenty
to thirty cells thick.

Lewis, in his paper, credits

Edgar Allen as the immediate stimulus for his idea for
the treatment of this specific vaginitie.

Allen had

demonstrated in his laboratory that one of the ef.fects
of estrogenic substances in the monkey wa.e an increase
in the thickness of the vaginal mucosa from a few cells
to many cells and a differentiation into two distinct
zones after about 21 days.

Lewie did not mention the

work of Loeb and Kountz (1928} in which they recorded the
results of experiments on guinea pigs with eetrogenic
substances.

Lewis and Weinstein (1938} reported several

years later that the use of the estrogens in this therapy
brought about a change in the pH of the vaginal tract from
a neutral to strongly acid secretion like that seen in
the adult

menetru~ting

woman.
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.

Before pubertl and after the cessation of activity . _
of the ovary, the fagina.J. mueoea is a delicate few· celled
mucous membrane
.

I
wi~I h

a neutral to faint.ly acid reaction.

I

During these years: it is an easy prey to invasion by
!

.

pathogenic baoteri4, espeo.ial.ly the gonoooooi.

This

organism and other~ are unable to live in"a pH of less
than 6.

In patien~s treated with estrogenio substance
I

the pH drops to 5

I

~r

less, appreaohing that seen during

the normal aotivi tyf of the ovary in the female.
I

On this

basis the treatmen~ of the senile and prepubertal types
i

of vaginitis ie f0'*1ded.
Lewis (1933) ~ttempted to reproduce the findiBgs of
Allen in ttie human

b~ing.

Hie report of e1iht oases treat-

ed with eetrogenio ~ubstanoe given hypodermioally 1n
.

I
I
I

•

.

whioh six complete loures were obtained and two oases
I
I

clinically oured bult returning later with an apparent
!

reinfection rather

,,

~han

a reourrenoe of the previous

infeotiOn 1s our fifst record of this type of ·treatment
for gonorrheal vagthi tis in children.

TeLinde and Brawn-

1

er (1935) were the first workers to use suppositories
I
I

rather than hypodetjnio injection of the eSJtrogen with
I

brilliant res'u1ts.

I

Pr8.tt and· Taomas (1937) found the

I

i

suppositories to bei vastly superior to the hypodermic·
injection of the

su~eta.noe. TeLinde

(1938) in a survey

!

of 175 oases found tra.l adminietrat ion··very ineffective,
I
I
I
I
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hypodermic injeot ion effective in most oases but that
looal application of the estrogen by means of suppositorie.s to be the most universally effective of all
methods.
weeks.
11 to 15

Treatment is

0011t inued

ideally for si'x ·to eight

The characteristic vaginal change is secured in
day~

and smears are _almost invariably_ negative

within an average of 17 to 19 days.

Dosages are from

50 to 100 rat units per day, twice to four times a week
(Falk, 1938).

TeLinde's series (1938) showed no case

that' failed to respond to this therapy.
treatment is a dra:wback.

Expense of the

It o'8ts as an avera.ge from et

eight to ten do11a,rs for the necessary amount of estrogenio eubetanoe.

As a result .other methods -of treatment

are being developed along other than

en.d~orinologidll

lines.
Until even more recently the treatment of senile
or postmenopausal vaginitis has been very ineffective.
After cessation of the estrogenio influence of the ovary,
the vaginal mucosa as depicted ab01te, reverts back to the
thin structure of the prepuberta.l period of life.

The

seoretuibs are no longer acid and the mucosa becomes e
easily infected.

When infected, the patients complain

of burni?lg, itching or pain in the vagina and coitus is
practically impossible.

Davis (1935) reported remarkable

success in treating these cases with 81miotin (an estrogen) subcutaneously.

In the majority of oases he ad.min-
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istered 100 rat unite of amniotin three times each week
for about six weeks.
within 10 days.
findings in 1S36.

S.ymptomatic relief was obtained

Jaooby and Rabbiner confirmed De.vie'
It bll.s been foilnd that vaginal supp-

ositories 1n this type· of vagini tis a.re not as satisfa()'I;
t ory as the hypodermic administration.
Another aide of the polygonal subject of the sex
hormones has been their chemical structure and the olose
similarity that· exists bc.,tween them and the sterols:, the
male sex hormone and especially the carcinogenic hydrogenated phenanthrene ring compounds.

Since about 1930

much literature has been published on these substances.
Most progress is in. the isolation of the crystalline
substance, discovery of their structural formulae and
their synthetic product ion.
The estrogenic hormone was the first known of the
ovarian hormone• anci was thought for
eole horrrone of menstruation.

a time

to be the

Considerable .arguemen t

wee rampant fran 1926 to 1928 as to whether there was
another hormone of menstruat i04.

The crystalline estrone

was isolated in 1929. fr'lln the.urine -c;>f. pregna.nt,:ll:omen.
Since then, estrone has been isolated from many sources,
animal, plant and inanimate. Its chemical structure
shows it to be basically like the phenanthrene ring
group of 9ompmmds, namely morphine, the bile salts,
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ergosterol, vitamine D, etc.

..

\,\

group
The corpus luteum hormone was discovered in 1934
and. its chemical structure· worked out in the ea.me year
by Butenandt.

He derived his pure product from etig-

maeterol and pregna.nediol.

His formula ie given here:

..

Corpt.?.s luteum hormone
.
(progesterone)
·
Perhaps of more interest to the

ge~eral

profession

at this time is not so muoh the exact whereabouts of the
double

b~ds

or the pos11;1on of the keto- .or alcohol

group but rather the similar! ty whioh we· see in the
structural formulae of these hormones and the c1:lrc1nogenic subetances of the·:tar series.

Yamagiwa and Ich-

ikowa described the experimental production of cancer
in rabbits with tar in 1915.

Kennaway, Cook, Kager and

others showed repeatedly that the oaroin·ogenic compounds
contained a hydrogenated phenanthrene ring. (Novak, 1937)
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The presence of this ring in both these carcinogenic
substances a.nd the eetrogenic substances; the fact that
certain members of the coal tar series have been definitely established as being estrogenic; the extensive proliferation of the endometrium during the postmen8trual
phase under the influence of eetrin, a process so comparable to carcin()Jja in· rapidity and extent of growth;
certain experiments which seem to indicate a probability
t bat est rogenic substances may, under certain conditbons
become carcinogenic; all lend credulity to the idea

th~t

the estrogens are possibly potentially oarcinogenic.
Novak and Yui, in an article on endom.etrial hyperplaeiae (1936) , cone idered t hie point fairly thoroughly.
Novak (1937) in an article a year later again emphasized
the close correlation of structure.

He comments on the

frequency in which eetrin is fpund in the urine of women
long after the menopause and even after surgical castration.

His conclusion that, since the placenta will dur-

ing pregnancy produce large amo1.mte of eetrin, other organs could do likewise.

One must remember, however, the

origin of the eetrin producing port ion of the placenta
may be the residual granuloea cells that

accomp~ny

·the

ovum to the uterus where it implants, a factor not present in any of the other organs in the body.

Novak and

Yui, in their study of 864 oases of hyperplasia of the

-soendometrium and 104 oases of adenocarcinoma of the
fundus of the uterus, correlated what seemed to be
sµffioient evidence for Novak (1937) to state that,
•the inference would. seem justified then that a
poetmenstrual endom.etrium suf jected to a ·persistent
eetrogenio stimulation 1 s predisposed to carcinoma.•
In the breast, repeated injections of estrin have
apparently produced cancer in a surprising number of
laboratory animals and, once started the malignant
process continues even after the hormone is withdrawn.
A cancer-like picture has been produced in the cervices

,-.
'

of mice by Perry (1936) and Loeb, et al (1936) using
eetrogenio substance•.
In direct contrast, Roberts (1S36) stressed the
faotor of heredity rather than the sex hormones in the
etioaogy of cancer.

He tends to mil:iimizes the r~le of

the hormones 1n the cause of cancer.

Macklin a number

of year~ ago (1933) analyzed a number of oases of entodermal tumors and found that such tumors were twice as
oom.1Don 'in the male as in the female.

She grudgingly

admits the possibility of the sex hormones being a factor but tends to depreciate the likelihood.
that heredity plays a much greater role.

She feels
She says, •the

explanation of this increased incidence 1n the male
appears to rest up9n factors inherent in the male con-
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etitution; factors which are genetic (sex linked) in
their basis and not merely dependent upon hormonal
infltences arising from male

gon~al

tissue."

None-the-less, this close chemical relationship
admits- th• possilJility of the ;formation d

oarcinogen-

ous substances from the sterol compounds by eome abnormality of _metabolism.

Cook (1933) pointed out that

such a transformation would involve only reduction,
dehydration and dehydrogenation, processes whdch readily oaour in the animal body normally.

This is indeed

a very promising lead for those in cancer research.
Many a.re now working on such phases of the cancer issue
at this time and it ie not improbable that new developments may be forthcoming soon either in refutation or
support of · the t heo ;r.

SUMMARY
1. The endocrine system is normally in a state of hlper-

feat balance, the control of which seems to center for
the most part_ in the

~"nte.rior

pituitary gland.

There

may be a central nervous system control, however.

2. Estrone is the ovarian hormone of the first 1-lf of
the cycle and progesterone of the last half of the menet rual ay ole-.

·3. The

va.r~oua

trop:io

·se·cr~t

ions· of the adenopituita.ry

are very closely related and may be produced from t_be

-ea.;;
same cell (be.eophile).
4. Indioe.t 1one for the use of estrone and pro.gesterone
during the menstrual cyele are rather definite. 'The
amounts required to produce all of the phenomeaa1..of the
menatrual cycle has also been worked out.
5. Substitutive therapy, though expenaive and nonaurative,
is a step in the right direction· especially for young
individuals in that it rehabilitates the individual not·
only physically but mentally; it makes their lives more
comfortable and liveable thereby.
6. Generally speaking, large doses of the endocrines tend
to depress that gland while small doses are stimulating.
Thie may be due to a direct effect, and effect mediated
through the pituitary gland, or to the formation of antihormonee.
7. In considering the/cause of any malfunction of menstruation, we must consider at least tbree glands, the ovary,
. the adenopituitary and the thyroid gland.
8. Primary amenorrhea and the menopause are -essentially
express ions of the same disturbance, a hypo-ovarianism.
The ovarian aot.ivity in the amenorrhea may be due seoonde.rUy to pituitary or thyroid pathology or it may be like
tht of the menopause, an ovarian failure or hypofunotion.
9. Whole ovarian substance and the estrogens are our most
effacious treatmentror alleviation of the menopausal eymp-
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toms.
10. J)ySmJJnorrhea of funot ional nature may be due to
either a hyper-eetrinization or to too muoh progesterone.

Treatment is an effort to supply the necess-

ary annagonist to buffer the \iormone that is present
in exoees.
ll. Excessive bleeding must be correctly diagnosed,
most preferably by biopsy.

A careful esamination of

the endocrine system is eseentlial, espedi_ally the
thyroid and the ovary.

Treatment depends upon the

cause of the symptom.
12. Arrhenoblaetomata (me.sculinizing tumors) and granuloee. cell tumors (estrin producing tumors) are the only
two ovarian tumors of endocrinological importance.

Treat-

ment for both is surgical. or irradiation.

CONCLUSIONS
l. The subject of endocrinology is a young one which is
st ill ppen

t.o mueh investigation and revision before

we can expeot stability.
2 •• Glande of internal secretion may refleot their abncr"ral
function by influencing the pituitary's control Of some
other gland.
3. It must be remembered that the endocrine system is ,an
imperf eotly balanced set of glands.

Deviations in one
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gland may ma:nif est itself frequently as upsets in the
endocrine balance rather than ust too much or too little
of that one glandular secretion.
4. Thyroid substance or thyroxin ie our cheapest, most
available and most generally eff aciou.a endocrine product.
5. The treatment of menstrual aberrations should be on
the basis of etiological factors.
6. The carcinogenic relat ionahip of the ovarian hormones
ie an unsolved problem so far.

Evidence so far seems

to indicate a probable indictment of the sex hormones._ . _
7. The past two decades have seen discoveries in the field
(""\

of endocrinology which have been startling 1n
and kaleidoscopic in their rapidity,
said about these substances.

th~ir

scope

All has not been

We can expect more discov-

eries and revisions in the next

~ew

years.
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